华厦眼科：接受惠璞投资调研

Company Overview - Huaxia Eye Hospital (SZ 301267) announced an investor research meeting scheduled for September 16, 2025, where the company’s board secretary and securities representatives will address investor inquiries [1] Financial Performance - For the first half of 2025, Huaxia Eye Hospital's revenue composition is as follows: Refractive services account for 36.9%, comprehensive optometry projects for 24.04%, cataract services for 20.14%, posterior segment projects for 12.94%, and other services for 5.99% [1] - As of the report date, Huaxia Eye Hospital has a market capitalization of 17.9 billion yuan [1]